Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems

被引:43
作者
ElHameed, MDA [1 ]
Kellaway, IW [1 ]
机构
[1] UNIV WALES COLL CARDIFF,WELSH SCH PHARM,CARDIFF CF1 3XF,S GLAM,WALES
关键词
mucoadhesive polymers; microsphere preparation; nasal delivery;
D O I
10.1016/S0939-6411(97)00101-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microspheres of hydrophilic polymers were prepared by the w/o emulsification solvent evaporation technique with a potential application as drug carriers for nasal administration by insufflation. The microspheres had a median particle size of 38 +/- 1.7 mu m (Carbopol 934P), 38.6 +/- 1.8 mu m (Chitosan), 33.6 +/- 7.2 mu m (HPMC), and 16.5 +/- 4.3 mu m (PVA) prepared using a stirring speed of 2000 rpm for 4 or 4.5 h at 80 degrees C. Chitosan and PVA microspheres were spherical and smooth-surfaced while Carbopol 934P and HPMC were of irregular shape with a rough surface morphology. For Carbopol 934P, the microsphere size was inversely proportional to stirring speed (1200-2000 rpm), and to the percentage of the emulsifier (Arlacel A, 0.2-1% w/w) and proportional to the percentage of core materials (0.2-0.5% w/w). FITC-dextran (Mw 4300 Dal was incorporated into the microspheres with an efficiency of 81 +/- 3.6% (Carbopol 934P), 55 +/- 20% (PVA), 44 +/- 6.7% (HPMC), and 36 +/- 2.7% (Chitosan). The change in initial concentration of FITC, dextran (0-15% w/w) had no effect on the particle size of Carbopol 934P microspheres. The rank order of mucoadhesion for the polymeric microspheres was Carbopol 934P > Chitosan = PVA = HPMC, although Chitosan was > HPMC. The change in content of FITC-dextran showed no significant effect on the mucoadhesive strength of Carbopol 934P microspheres within the concentration range of 0-12% w/w. The FITC-dextran was released from the microspheres initially at a constant rate. However the release rate subsequently decreased over the 24 h test period. No differences were observed for release from Carbopol 934P, PVA and HPMC: all exhibited faster release than that achieved from the Chitosan microspheres which exhibited a size-dependent release effect. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 27 条
[1]   CONTROLLED-RELEASE SALBUTAMOL SULFATE MICROCAPSULES PREPARED BY EMULSION SOLVENT EVAPORATION TECHNIQUE AND STUDY ON THE RELEASE AFFECTED PARAMETERS [J].
AMPERIADOU, A ;
GEORGARAKIS, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) :1-8
[2]  
BARKAI A, 1989, P 8 PHARM TECH C MON, V1, P11
[3]   MICROSPHERES OF HYALURONIC-ACID ESTERS - FABRICATION METHODS AND INVITRO HYDROCORTISONE RELEASE [J].
BENEDETTI, LM ;
TOPP, EM ;
STELLA, VJ .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (01) :33-41
[4]   MICROENCAPSULATION OF PARACETAMOL USING POLYACRYLATE RESINS (EUDRAGIT RETARD), KINETICS OF DRUG RELEASE AND EVALUATION OF KINETIC-MODEL [J].
BENITA, S ;
HOFFMAN, A ;
DONBROW, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (06) :391-395
[5]   DEGRADABLE STARCH MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR INSULIN [J].
BJORK, E ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :233-238
[6]  
CHIEN YW, 1987, CRC CR REV THER DRUG, V4, P67
[7]   PRECORNEAL CLEARANCE OF MUCOADHESIVE MICROSPHERES FROM THE RABBIT EYE [J].
DURRANI, AM ;
FARR, SJ ;
KELLAWAY, IW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (07) :581-584
[8]   MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS [J].
EDMAN, P ;
BJORK, E ;
RYDEN, L .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :165-172
[9]   INTRANASAL ADMINISTRATION OF PEPTIDES - NASAL DEPOSITION, BIOLOGICAL RESPONSE, AND ABSORPTION OF DESMOPRESSIN [J].
HARRIS, AS ;
NILSSON, IM ;
WAGNER, ZG ;
ALKNER, U .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (11) :1085-1088
[10]   EFFECT OF VISCOSITY ON THE PHARMACOKINETICS AND BIOLOGICAL RESPONSE TO INTRANASAL DESMOPRESSIN [J].
HARRIS, AS ;
OHLIN, M ;
SVENSSON, E ;
LETHAGEN, S ;
NILSSON, IM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (06) :470-471